Type 1 Narcolepsy in Pregnancy: A Case Report and Review of Literature

Abstract

Background Type 1 narcolepsy (with cataplexy) is a rare disorder affecting the central nervous system and is characterized by the inability to control sleep–wake cycles. There is a paucity of data regarding management during pregnancy.

Case This is a 23-year-old primigravida with narcolepsy and cataplexy, treated with methylphenidate in the third trimester, resulting in an improvement of episodes of cataplexy. A review of the literature reveals information regarding options for medical management and the mode of delivery for these women.

Conclusion Type 1 narcolepsy can be treated with medications after consideration of risks and benefits. For patients who are symptomatic at the time of birth, cesarean section may be the preferred mode of delivery in women with type 1 narcolepsy.

Keywords

type 1 narcolepsy - cataplexy - pregnancy - delivery - obstetric - Ceserean Section - medications

Publication History

Received: 16 November 2023

Accepted: 27 March 2024

Accepted Manuscript online:
01 April 2024

Article published online:
26 April 2024

• References

• 1 Bhattarai J, Sumerall S. Current and future treatment options for narcolepsy: a review. Sleep Sci 2017; 10 (01) 19-27
• 2 Narcolepsy. National Institute of Neurological Disorders and Stroke, U.S. Department of Health and Human Services. Accessed April 4, 2024 at: www.ninds.nih.gov/health-information/disorders/narcolepsy
• 3 Mignot E, Zeitzer J, Pizza F, Plazzi G. Sleep problems in narcolepsy and the role of hypocretin/orexin deficiency. The Orexin System. Front Neurol Neurosci 2021; 45: 103-116
• 4 Scammell TE, Winrow CJ. Orexin receptors: pharmacology and therapeutic opportunities. Annu Rev Pharmacol Toxicol 2011; 51: 243-266
• 5 Wilson A, Dongarwar D, Carter K, Marroquin M, Salihu HM. The association between narcolepsy during pregnancy and maternal-fetal risk factors/outcomes. Sleep Sci 2022; 15 (03) 297-304
• 6 National Institute of Neurological Disorders and Stroke (NINDS). Narcolepsy fact sheet. Bethesda: National Institutes of Health; 2015
• 7 Silvestri R, Aricò I. Sleep disorders in pregnancy. Sleep Sci 2019; 12 (03) 232-239
• 8 Khan SS, Mujuruki C. (2023). Medication management of patient with narcolepsy during pregnancy and lactation. In: Khan SS, Khawaja IS. eds. A Clinical Casebook of Sleep Disorders in Women. Cham: Springer; DOI: 10.1007/978-3-031-24200-7_10
• 9 Pascoe M, Carter LP, Honig E, Bena J, Foldvary-Schaefer N. Pregnancy and contraception experiences in women with narcolepsy: a narcolepsy network survey. J Clin Sleep Med 2019; 15 (10) 1421-1426
• 10 Ping LS, Yat FS, Kwok WY. Status cataplecticus leading to the obstetric complication of prolonged labor. J Clin Sleep Med 2007; 3 (01) 56-57
• 11 Williams SF, Alvarez JR, Pedro HF, Apuzzio JJ. Glutaric aciduria type II and narcolepsy in pregnancy. Obstet Gynecol 2008; 111 (2 Pt 2): 522-524
• 12 Hoque R, Chesson Jr AL. Conception, pregnancy, delivery, and breastfeeding in a narcoleptic patient with cataplexy. J Clin Sleep Med 2008; 4 (06) 601-603
• 13 Kaplan S, Braverman DL, Frishman I, Bartov N. Pregnancy and fetal outcomes following exposure to modafinil and armodafinil during pregnancy. JAMA Intern Med 2021; 181 (02) 275-277
• 14 Teva Pharmaceuticals Ireland. Modafinil: potential risk of congenital malformations when administered during pregnancy. Accessed November 19, 2023 at https://www.hpra.ie/docs/default-source/default-document-library/important-safety-information---modafinil99170c2697826eee9b55ff00008c97d0.pdf
• 15 American Academy of Pediatrics. Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 2001; 181 (02) 776-789
• 16 U.S. Food and Drug Administration. Accessed April 4, 2024 at www.fda.gov